相关实验视频

Updated: Jan 8, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

关于欧洲移民肺结核查的多国德尔菲共识

Marina Pinheiro^1,2,3,4, Ana Aguiar^5,2,4, David N Moreira¹

¹Barcelos/Esposende Local Health Unit, Public Health Unit, Barcelos/Esposende, Portugal.

ERJ open research

|December 24, 2025

概括

移民在欧洲面临着高结核病 (TB) 负担. 这项研究制定了统一结核病查和护理的协调建议,强调免费获取,文化敏感性和协调努力,以有效控制结核病.

科学领域:

公共卫生公共卫生
移民卫生移民卫生
传染病流行病学传染病流行病学

背景情况:

结核病 (TB) 不成比例地影响世卫组织欧洲地区的移民.
目前的结核病查和感染 (TBI) 建议在欧洲各国有很大差异.
对于标准化的实践和协调的策略来减轻移民人口中的结核病风险,这是非常必要的.

研究的目的:

制定统一的,基于共识的推,针对欧洲移民的结核病查和护理.
在这个弱势群体中为结核病控制提供政策制定和可行的干预措施的信息.
解决目前欧洲对移民结核病的应对措施中存在的差距和弱点.

主要方法:

利用德尔菲方法在专家之间达成共识.
召开了一个由来自22个国家的33名结核病专家组成的多学科小组.
在四个关键领域制定了19个共识声明和36个建议.

主要成果:

该小组提出了全面的建议,涵盖政策,卫生系统,查程序,优先人口以及持续的治疗和护理.
关键建议包括采取统一的,基于证据的方法来对移民进行结核病查.
重点是免费获得诊断和治疗,文化敏感的护理以及数字工具的整合.

结论:

统一的,以证据为基础的方法对于在欧洲移民中有效和公平的结核病控制至关重要.
建议平衡卫生系统的直接干预与文化包容性查和护理策略.
实施这些建议可以推动消除结核病作为欧洲公共卫生威胁的努力.

更多相关视频

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

相关概念视频

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: